Leukemia, Lymphoma & Hematologic Cancer

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

FMS related tyrosine kinase 3 (FLT3) is a frequently mutated receptor tyrosine kinase in Acute Myeloid Leukemia. Novel Tyrosine kinase inhibitors against FLT3 are currently in clinical trial. Discover the latest research on FLT3 Inhibitors in Acute Myeloid Leukemia here.

Hodgkin disease or Hodgkin's lymphoma is a type of lymphoma that affects the lymph system. Here is the latest research on Hodgkin disease.

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Hairy cell leukemia is a type of blood cancer involving the excess production of lymphoytes. Here is the latest research on hairy cell leukemia.

T-cell leukemia includes various types of lymphoid leukemia that affect T cells. Here is the latest research on T-cell leukemia.

Lymphoid neoplasms are derived from cells that frequently have features that recapitulate stages of normal b-, t-, and nk-cell differentiation and function. Lymphoid neoplasms include the following morphologic types: follicular center cell, lymphoblast (lymphocytic), immunoblast, plasma cell, and large granular lymphocyte (lgl). Here is the latest research on lymphoid neoplasms.

B-Cell Lymphoma includes types of lymphomas that affect B cells. Here is the latest research on B-Cell lymphoma.

Follicular lymphoma is a slow-growing non-Hodgkin lymphoma involving B-lymphocytes. Here is the latest research on follicular lymphoma.

Mantle cell lymphoma is an aggressive . B-cell non-Hodgkin lymphoma that develops around the lymph node's outer edge (mantle zone). Here is the latest research on mantle cell lymphoma.

T-cell lymphoma includes various types of lymphomas that affect T cells. It can be found in the blood, lymph nodes, skin, or other areas of the body. Here is the latest research on T-cell lymphoma.

Mixed lineage leukemia-1 (MLL-1) is a particular type of acute leukemia from the mutation of the MLL/KMT2A gene. This mutation can be seen in pediatrics, adults and therapy-induced acute leukemia’s. Discover the latest research on MLL-r leukemia here.

Multiple myeloma is a cancer of the plasma cells, which normally is involved in antibody production. Discover the latest research on Multiple myeloma here.

Myelodysplastic syndromes are cancers in which immature blood cells in the bone marrow do not mature to become healthy blood cells. Discover the latest research on this cancer here.

Chronic Myeloid Leukemia (CML) is a stem cell cancer that arises due to the fusion and constitutive expression of BCR-ABL1 in hematopoietic stem cells, which give rise to both myeloid and lymphoid cell lineages. CML is characterized by increased and unregulated proliferation of myeloid cells. Here is the latest research.

MDSC (myeloid-derived suppressor cells) are a heterogenous group of immune cells from the myeloid lineage. MDSCs strongly expand in pathological situations such as chronic infections and cancer, as a result of an altered haematopoiesis. MDSCs are discriminated from other myeloid cell types in which they possess strong immunosuppressive activities rather than immunostimulatory properties.

Preleukemia refers to a hemic and lymphatic disease in which the bone marrow does not produce enough blood cells. Here is the latest research.